Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	369.46B -8.7%
Revenue (ttm)	110.99B +12.7%
Net Income	9.06B -39.9%
EPS	963.99 -39.3%
Shares Out	10.32M
PE Ratio	37.14
Forward PE	8.73
Dividend	660.00 (1.88%)
Ex-Dividend Date	Apr 2, 2026

Volume	46,027
Average Volume	91,137
Open	35,450
Previous Close	35,150
Day's Range	35,150 - 36,050
52-Week Range	33,050 - 77,200
Beta	0.42
RSI	40.76
Earnings Date	May 12, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.